| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/JNNP.59.3.316 |
| P953 | full work available at URL | https://jnnp.bmj.com/content/jnnp/59/3/316.full.pdf |
| https://europepmc.org/articles/PMC486040 | ||
| https://europepmc.org/articles/PMC486040?pdf=render | ||
| https://syndication.highwire.org/content/doi/10.1136/jnnp.59.3.316 | ||
| P932 | PMC publication ID | 486040 |
| P698 | PubMed publication ID | 7673966 |
| P5875 | ResearchGate publication ID | 15525124 |
| P2093 | author name string | K. Maekawa | |
| T. Matsuishi | |||
| Y. Hirano | |||
| E. Ohtaki | |||
| P2860 | cites work | Estimability and estimation in case-referent studies | Q34169256 |
| Protection against Japanese encephalitis by inactivated vaccines | Q40783257 | ||
| Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination | Q41854384 | ||
| Physical reactions following vaccination against Japanese B encephalitis--with special reference to neurological complications | Q44155312 | ||
| Japanese encephalitis: report of a World Health Organization Working Group | Q70193136 | ||
| JAPANESE B encephalitis vaccine | Q82347727 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Beijing | Q956 |
| encephalitis | Q199615 | ||
| acute disseminated encephalomyelitis | Q424242 | ||
| Japanese encephalitis virus | Q19838331 | ||
| P304 | page(s) | 316-317 | |
| P577 | publication date | 1995-09-01 | |
| P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
| P1476 | title | Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains) | |
| P478 | volume | 59 |
| Q36178370 | A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines |
| Q73851192 | Acute disseminated encephalomyelitis after live rubella vaccination |
| Q33920424 | Acute disseminated encephalomyelitis associated with poliomyelitis vaccine |
| Q40597111 | Acute disseminated encephalomyelitis following aseptic meningoencephalitis |
| Q37934056 | Acute disseminated encephalomyelitis following influenza vaccination. |
| Q73284752 | Acute disseminated myelitis after Japanese B encephalitis vaccination |
| Q43948486 | Acute transverse myelitis after Japanese B encephalitis vaccination in a 4-year-old girl |
| Q35643929 | Allergic reactions to Japanese encephalitis vaccine |
| Q43041486 | Analysis of ChimeriVax Japanese Encephalitis Virus envelope for T-cell epitopes and comparison to circulating strain sequences |
| Q38029858 | Biologically plausible and evidence-based risk intervals in immunization safety research |
| Q28237906 | Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis |
| Q40202213 | Duration of neutralizing antibody titer after Japanese encephalitis vaccination |
| Q31115845 | Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data |
| Q30857727 | Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus |
| Q37519659 | IC51 Japanese encephalitis vaccine |
| Q43000995 | Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines |
| Q37622889 | Ixiaro: a new vaccine against Japanese encephalitis |
| Q58999704 | Japanese Encephalitis Virus Generated Neurovirulence, Antigenicity, and Host Immune Responses |
| Q27010434 | Japanese encephalitis: the virus and vaccines |
| Q27477893 | Japanese viral encephalitis |
| Q27469763 | Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). |
| Q42977550 | Neurological complications and Japanese encephalitis vaccination |
| Q42998699 | New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998. |
| Q33835377 | North American encephalitic arboviruses |
| Q40799911 | Oral immunisation of mice with live Japanese encephalitis virus induces a protective immune response |
| Q35666240 | Poly-γ-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus |
| Q42977444 | Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated). |
| Q37350360 | Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses |
| Q34392982 | Travel vaccines and elderly persons: review of vaccines available in the United States. |
Search more.